Enzo Patent Invalid Due To Sale Of Technology Prior To Issuance
A patent for disease-diagnosing probes, asserted by Enzo Biochem Inc., is invalid due to a controversial transaction made more than a year before it was issued, the U.S. Court of Appeals...To view the full article, register now.
Already a subscriber? Click here to view full article